A detailed history of Pensionmark Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pensionmark Financial Group, LLC holds 48,390 shares of ABBV stock, worth $8.63 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
48,390
Previous 93,580 48.29%
Holding current value
$8.63 Million
Previous $18.5 Million 48.29%
% of portfolio
0.31%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

SELL
$163.84 - $199.33 $7.4 Million - $9.01 Million
-45,190 Reduced 48.29%
48,390 $9.56 Million
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $6.79 Million - $8.26 Million
41,459 Added 79.54%
93,580 $18.5 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $7.71 Million - $9 Million
49,789 Added 2135.03%
52,121 $8.94 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $131,531 - $149,868
-823 Reduced 26.09%
2,332 $424,000
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $434,128 - $488,930
3,155 New
3,155 $488,000
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $2,549 - $2,924
19 Added 0.39%
4,857 $652,000
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $4,816 - $6,123
35 Added 0.73%
4,838 $690,000
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $55,167 - $68,447
-418 Reduced 8.01%
4,803 $779,000
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $51,566 - $65,246
-480 Reduced 8.42%
5,221 $752,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $7,448 - $8,454
70 Added 1.24%
5,701 $615,000
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $4,734 - $5,274
45 Added 0.81%
5,631 $634,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $112,120 - $123,431
1,096 Added 24.41%
5,586 $659,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $361,400 - $487,928
4,490 New
4,490 $470,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pensionmark Financial Group, LLC Portfolio

Follow Pensionmark Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionmark Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pensionmark Financial Group, LLC with notifications on news.